Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

MLA

Batista, Denise da Gama Jaén, et al. “Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas’ Disease Treatment.” Antimicrobial Agents and Chemotherapy, vol. 54, no. 7, July 2010, pp. 2940–52. EBSCOhost, https://doi.org/10.1128/AAC.01617-09.

APA

Batista, D. da G. J., Batista, M. M., de Oliveira, G. M., do Amaral, P. B., Lannes-Vieira, J., Britto, C. C., Junqueira, A., Lima, M. M., Romanha, A. J., Sales Junior, P. A., Stephens, C. E., Boykin, D. W., & Soeiro, M. de N. C. (2010). Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas’ disease treatment. Antimicrobial Agents and Chemotherapy, 54(7), 2940–2952. https://doi.org/10.1128/AAC.01617-09

Chicago

Batista, Denise da Gama Jaén, Marcos Meuser Batista, Gabriel Melo de Oliveira, Patrícia Borges do Amaral, Joseli Lannes-Vieira, Constança Carvalho Britto, Angela Junqueira, et al. 2010. “Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas’ Disease Treatment.” Antimicrobial Agents and Chemotherapy 54 (7): 2940–52. doi:10.1128/AAC.01617-09.